Vorinostat
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7e45eb7-08a5-2a3a-66d7-74a79fd3f15a | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-015-01 | Vorinostat | 500 g in 1 JAR | POWDER | 500 | 2 | |
| 73309-015-02 | Vorinostat | 1000 g in 1 JAR | POWDER | 1000 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 73309-015 | 73309-015-01, 73309-015-02 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| VORINOSTAT | 58IFB293JI | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZOLINZA | VORINOSTAT | Merck Sharp & Dohme LLC | cd86ee78-2781-468b-930c-3c4677bcc092 | 2024-11-12 | Warnings, Adverse reactions | VORINOSTAT |
Adverse event summaries are temporarily unavailable. Other product information remains available.